Overview
Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.
Indication
For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
Associated Conditions
- Withdrawal Nicotine
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2024/12/20 | Not Applicable | Completed | |||
2024/09/19 | Not Applicable | Completed | |||
2024/09/19 | Phase 4 | Recruiting | |||
2024/09/05 | Not Applicable | Not yet recruiting | |||
2024/08/15 | Phase 3 | Active, not recruiting | |||
2024/08/09 | Phase 4 | Recruiting | |||
2024/08/02 | Phase 4 | Not yet recruiting | |||
2024/06/25 | Phase 4 | Recruiting | |||
2024/03/27 | Early Phase 1 | Not yet recruiting | |||
2024/03/18 | Phase 2 | Recruiting |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
---|---|---|---|---|---|
Rite Aid Corporation | 11822-3315 | ORAL | 2 mg in 1 1 | 8/20/2025 | |
Bryant Ranch Prepack | 72162-2266 | ORAL | 2 mg in 1 1 | 8/26/2025 | |
Walgreen Company | 0363-7269 | ORAL | 2 mg in 1 1 | 2/27/2025 | |
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 55910-976 | ORAL | 4 mg in 1 1 | 1/29/2025 | |
P & L Development, LLC | 59726-913 | ORAL | 4 mg in 1 1 | 9/9/2025 | |
Lucy Goods, Inc. | 72224-927 | ORAL | 2 mg in 1 1 | 4/28/2025 | |
Lucy Goods, Inc. | 72224-933 | ORAL | 4 mg in 1 1 | 4/29/2025 | |
Meijer Distribution Inc | 41250-456 | ORAL | 2 mg in 1 1 | 2/18/2025 | |
CVS Pharmacy | 69842-028 | BUCCAL | 4 mg in 1 1 | 8/1/2025 | |
Target Corporation | 11673-194 | TRANSDERMAL | 21 mg in 24 h | 6/10/2025 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
---|---|---|---|
No EMA approvals found for this drug. |
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
NICOTINELL MINT 2mg CHEWING-GUM | FERTIN PHARMA A/S (7100) | SIN12569P | GUM, CHEWING | 2 mg | 7/27/2004 |
Nicorette Icy Mint Medicated Chewing Gum 2mg | SIN14326P | GUM, CHEWING | 2mg | 3/12/2013 | |
NICOTINELL MINT LOZENGE 1 mg | Swissco Services AG | SIN11732P | LOZENGE | 1 mg | 11/27/2001 |
Nicorette Invisi Transdermal Patch 10mg/16 hours | SIN14294P | PATCH, EXTENDED RELEASE | 15.75 mg/9 sq cm | 1/17/2013 | |
SKIIP NICOTINE MINI LOZENGE 2 MG (Cinnamon) | SIN17062P | LOZENGE | 2.00 mg | 8/14/2024 | |
SKIIP NICOTINE MINI LOZENGE 2 MG (CHERRY) | SIN17060P | LOZENGE | 2.00 mg | 8/14/2024 | |
SKIIP NICOTINE MINI LOZENGE 4 MG (Cherry) | SIN17061P | LOZENGE | 4.00 mg | 8/14/2024 | |
SKIIP NICOTINE MINI LOZENGE 4 MG (Cinnamon) | SIN17063P | LOZENGE | 4.00 mg | 8/14/2024 |
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
---|---|---|---|---|---|
No NMPA approvals found for this drug. |
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
---|---|---|---|---|---|
No PPB approvals found for this drug. |
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Health Canada Drug Approvals
View More Health Canada Approvals
Sign in to access additional Health Canada approved drug information with detailed regulatory data.
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
---|---|---|---|---|---|
No Health Canada approvals found for this drug. |
CIMA AEMPS Drug Approvals
View More CIMA AEMPS Approvals
Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
---|---|---|---|---|---|
NICOTINELL 7 MG/24 HORAS PARCHE TRANSDERMICOS | Haleon Spain S.A. | 68302 | PARCHE TRANSDÉRMICO | Sin Receta | Commercialized |
NICOTINELL 21 MG/24 HORAS PARCHE TRANSDERMICO | Haleon Spain S.A. | 68303 | PARCHE TRANSDÉRMICO | Sin Receta | Commercialized |
NICOTINELL FRUIT 4 mg CHICLE MEDICAMENTOSO | Haleon Spain S.A. | 65586 | CHICLE MEDICAMENTOSO | Sin Receta | Commercialized |
NIQUITIN CLEAR 7 MG/24 H PARCHES TRANSDERMICOS | Perrigo Espana S.A. | 65840 | PARCHE TRANSDÉRMICO | Sin Receta | Commercialized |
NIQUITIN CLEAR 21 MG/24 HORAS PARCHE TRANSDERMICO | Perrigo Espana S.A. | 65842 | PARCHE TRANSDÉRMICO | Sin Receta | Commercialized |
Philippines FDA Drug Approvals
View More Philippines FDA Approvals
Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Philippines FDA approvals found for this drug. |
Saudi SFDA Drug Approvals
View More Saudi SFDA Approvals
Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Saudi SFDA approvals found for this drug. |
Malaysia NPRA Drug Approvals
View More Malaysia NPRA Approvals
Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
---|---|---|---|---|---|
No Malaysia NPRA approvals found for this drug. |
UK EMC Drug Information
View More UK EMC Drug Information
Sign in to access additional UK EMC drug information with detailed pharmaceutical data.
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
---|---|---|---|---|---|
No UK EMC drug information found for this drug. |
Help Us Improve
Your feedback helps us provide better drug information and insights.